Literature DB >> 27269010

Insurance Financing Increased For Mental Health Conditions But Not For Substance Use Disorders, 1986-2014.

Tami L Mark1, Tracy Yee2, Katharine R Levit3, Jessica Camacho-Cook4, Eli Cutler5, Christopher D Carroll6.   

Abstract

This study updates previous estimates of US spending on mental health and substance use disorders through 2014. The results reveal that the long-term trend of greater insurance financing of mental health care continued in recent years. The share of total mental health treatment expenditures financed by private insurance, Medicare, and Medicaid increased from 44 percent in 1986 to 68 percent in 2014. In contrast, the share of spending for substance use disorder treatment financed by private insurance, Medicare, and Medicaid was 45 percent in 1986 and 46 percent in 2014. From 2004 to 2013, a growing percentage of adults received mental health treatment (12.6 percent and 14.6 percent, respectively), albeit only because of the increased use of psychiatric medications. In the same period, only 1.2-1.3 percent of adults received substance use disorder treatment in inpatient, outpatient, or residential settings, although the use of medications to treat substance use disorders increased rapidly. Project HOPE—The People-to-People Health Foundation, Inc.

Entities:  

Keywords:  Health Economics; Health Reform; Health Spending; Medicaid; Mental Health/Substance Abuse

Mesh:

Year:  2016        PMID: 27269010     DOI: 10.1377/hlthaff.2016.0002

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  20 in total

1.  State variations in Medicaid enrollment and utilization of substance use services: Results from a National Longitudinal Study.

Authors:  Ramin Mojtabai; Kenneth A Feder; Marc Kealhofer; Noa Krawczyk; Carla Storr; Kayla N Tormohlen; Andrea S Young; Mark Olfson; Rosa M Crum
Journal:  J Subst Abuse Treat       Date:  2018-04-04

2.  The Effect of Public Insurance Expansions on Substance Use Disorder Treatment: Evidence from the Affordable Care Act.

Authors:  Johanna Catherine Maclean; Brendan Saloner
Journal:  J Policy Anal Manage       Date:  2019

3.  Evaluating the role of Section 1115 waivers on Medicaid coverage and utilization of opioid agonist therapy among substance use treatment admissions.

Authors:  Kayla N Tormohlen; Noa Krawczyk; Kenneth A Feder; Kira E Riehm; Rosa M Crum; Ramin Mojtabai
Journal:  Health Serv Res       Date:  2019-12-29       Impact factor: 3.402

4.  Increasing Access to Opioid Use Disorder Treatment: Assessing State Policies and the Evidence Behind Them.

Authors:  Jesse M Hinde; Tami L Mark; Laurel Fuller; Judith Dey; Jennifer Hayes
Journal:  J Stud Alcohol Drugs       Date:  2019-11       Impact factor: 2.582

5.  Perceived Impacts of the Affordable Care Act: Perspectives of Buprenorphine Prescribers.

Authors:  Hannah K Knudsen; Jamie L Studts
Journal:  J Psychoactive Drugs       Date:  2017-03-15

6.  Changes in Medicaid Acceptance by Substance Abuse Treatment Facilities After Implementation of Federal Parity.

Authors:  Kimberley H Geissler; Elizabeth A Evans
Journal:  Med Care       Date:  2020-02       Impact factor: 2.983

7.  Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities.

Authors:  Ramin Mojtabai; Christine Mauro; Melanie M Wall; Colleen L Barry; Mark Olfson
Journal:  Health Aff (Millwood)       Date:  2019-01       Impact factor: 6.301

8.  Commercial Health Plan Coverage of Selected Treatments for Opioid Use Disorders from 2003 to 2014.

Authors:  Sharon Reif; Timothy B Creedon; Constance M Horgan; Maureen T Stewart; Deborah W Garnick
Journal:  J Psychoactive Drugs       Date:  2017-03-28

9.  Association of Cost Sharing With Mental Health Care Use, Involuntary Commitment, and Acute Care.

Authors:  Bastian Ravesteijn; Eli B Schachar; Aartjan T F Beekman; Richard T J M Janssen; Patrick P T Jeurissen
Journal:  JAMA Psychiatry       Date:  2017-09-01       Impact factor: 21.596

10.  Specialty Substance Use Disorder Treatment Admissions Steadily Increased In The Four Years After Medicaid Expansion.

Authors:  Brendan Saloner; Johanna Catherine Maclean
Journal:  Health Aff (Millwood)       Date:  2020-03       Impact factor: 6.301

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.